SPRB
Spruce Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$60.06
+0.16 ▲ +0.27%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$60.06
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -52.72 | Insider Own | 18.03% | Shs Outstand | 0.00B | Perf Week | 7.5% |
| Market Cap | 0.08B | Forward P/E | - | EPS next Y | 13.38% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -27.37% |
| Enterprise Value | 0.03B | PEG | - | EPS next Q | -8.81 | Inst Own | 59.89% | Short Float | 11.09% | Perf Quarter | -29.89% |
| Income | -0.04B | P/S | - | EPS this Y | 27.76% | Inst Trans | 66.06% | Short Ratio | 3.18 | Perf Half Y | 582.5% |
| Sales | 0.00B | P/B | 1.94 | EPS next 5Y | 52.38% | ROA | -79.34% | Short Interest | 0.12M | Perf YTD | -31.05% |
| Book/sh | 30.99 | P/C | 1.68 | EPS past 3/5Y | 29.85% 11.8% | ROE | -109.24% | 52W High | -74.97% ($240.00) | Perf Year | 142.74% |
| Cash/sh | 35.65 | P/FCF | - | Sales past 3/5Y | - | ROIC | -90.76% | 52W Low | 1304.91% ($4.28) | Perf 3Y | -65.48% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 45.32% | Gross Margin | - | Volatility(W/M) | 11.65% 12.19% | Perf 5Y | -96.89% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 6.3 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.17 | EPS Q/Q | 75.01% | Profit Margin | - | RSI (14) | 45.77 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.17 | Sales Q/Q | -100% | SMA20 | 4.39% ($57.53) | Beta | 3.79 | Target Price | $198.25 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 3000000 | SMA50 | -15.28% ($70.89) | Rel Volume | 0.77 | Prev Close | $59.9 |
| Employees | 8 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 4.67% - | SMA200 | 9.54% ($54.83) | Avg Volume(3M) | 0.04M | Price | $60.06 |
| IPO | 2020/10/9 | Option/Short | No/Yes | Trades | 901 | Volume | 30,078 | Change | 0.27% |
뉴스 로딩 중...